Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?

Interactive Cardiovascular and Thoracic Surgery

Volumn 5, Issue 4, 2006, Pages 493-498

  Tanos, Marios ^a   Dunning, Joel ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bleeding; Blood products; Evidence based medicine; Factor VIIa; Haemostasis; Thoracic surgery

Indexed keywords

BLOOD CLOTTING FACTOR 7; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING; BLOOD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEART SURGERY; HEMOPHILIA; HEMOSTASIS; HUMAN; MORTALITY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOSIS; UNSPECIFIED SIDE EFFECT;

EID: 33746712294     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2006.134791     Document Type: Article

References (14)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-409.
2. Bishop CV, Renwick WEP, Hogan C, Haeusler M, Tuckfield A, Tatoulis J. Recombinant Activated Factor VII: treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg 2006;81:875-879.
3. Levi M, Peters M, Buller HR. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. [Review] [59 Refs]. Critical Care Medicine 2005;33:883-890.
4. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomised double-blind placebo-controlled pilot study. Br J Anaesth 2005;95:596-602.
5. Herbertson M. Recombinant activated factor VII in cardiac surgery. [Review] [4 Refs]. Blood Coagulation & Fibrinolysis 2004;15(Suppl 1):S31-S32.
6. von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Grosse J, Ziemer S, Koscielny J, Konertz WF, Wernecke KD, Spies C. Recombinant activated factor VII for refractory bleeding after cardiac surgery - a retrospective analysis of safety and efficacy. Crit Care Med 2005;33:2241-2246.
7. Hyllner M, Houltz E, Jeppsson A. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. Eur J Cardio-Thorac Surg 2005;28:254-258.
8. Karkouti K, Beattie WS, Wijeysundera DN, Yau TM, McCluskey SA, Ghannam M, Sutton D, van Rensberg A, Karski J. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion 2005;45:26-34.
9. Vanek T, Straka Z, Hrabak J, Jares M, Brucek PJ, Votava J. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding. Jpn Heart J 2004;45:855-860.
10. Aggarwal A, Malkovska V, Catlett JP, Alcorn K. Recombinant activated factor VII (RFVIIa) as salvage treatment for intractable hemorrhage. Thrombos J 2004;2:9.
11. Halkos ME, Levy JH, Chen E, Reddy VS, Lattouf OM, Guyton RA, Song HK. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery. Ann Thorac Surg 2005;79:1303-1306.
12. Roberts HR, Monroe DM III, Hoffman M. Safety profile of recombinant factor VIIa. [Review] [48 Refs]. Seminars in Hematology 2005;41(1 Suppl 1):101-108.
13. DiDomenico RJ, Massad MG, Kpodonu J, Navarro RA, Geha AS. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass. [Review] [32 Refs]. Chest 2005;127:1828-1835.
14. Al Douri M, Shafi T, Al Khudairi D, Al Bokhari E, Black L, Akinwale N, Osman MM, Al Homaidhi A, Al Fagih M, Borum AR. Effect of the administration of recombinant activated factor VII (RFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coag Fibrinolysis 200;11(Suppl 1):S121-127.